# Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Canonical URL: https://biopharmsignal.com/news/SHC/sotera-health-delivers-20th-consecutive-year-of-revenue-growth-and-provides-2026-outlook
Ticker: SHC
Company: Sotera Health
Source: Sotera Health
Published: 2026-02-24 12:00 EST
Original Source URL: https://investors.soterahealth.com
## Summary

2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 2024 2025 Adjusted EBITDA (1) increased 8.2% to $594

## Article Body
2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 2024 2025 Adjusted EBITDA (1) increased 8.2% to $594
## Recent Company News
- 2026-05-05 11:04 EST — [Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook](https://biopharmsignal.com/news/SHC/sotera-health-delivers-strong-first-quarter-2026-results-and-reaffirms-2026-outlook) — Source: Sotera Health
- 2026-05-05 11:00 EST — [Sotera Health Announces Leadership Transition](https://biopharmsignal.com/news/SHC/sotera-health-announces-leadership-transition) — Source: Sotera Health
- 2026-04-21 11:46 EST — [Sotera Health Announces First-Quarter 2026 Earnings Release Date](https://biopharmsignal.com/news/SHC/sotera-health-announces-first-quarter-2026-earnings-release-date) — Source: Sotera Health
- 2026-03-16 11:00 EST — [Sotera Health Appoints Kenneth D. Krause to the Board of Directors](https://biopharmsignal.com/news/SHC/sotera-health-appoints-kenneth-d-krause-to-the-board-of-directors) — Source: Sotera Health
- 2026-03-04 21:51 EST — [Sotera Health Announces Secondary Offering of Common Stock](https://biopharmsignal.com/news/SHC/sotera-health-announces-secondary-offering-of-common-stock) — Source: Sotera Health
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)